Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In this study, patients with alopecia areata who experienced sustained hair regrowth while being treated with baricitinib showed improvements in health-related quality of life and reductions in anxiety and depression symptoms over 104 weeks, according to the BRAVE-AA phase III trials.

Cyclosporine starts hair growth faster, while minoxidil makes it last longer.

This review discusses current treatment strategies for alopecia and highlights the potential of lipid-based nanoparticles to improve drug delivery to the scalp and hair follicles, noting their ability to enhance skin penetration and drug stability while outlining associated challenges and the need for further research.

In this study, adding δ34S isotope analysis to models modestly improved precision in estimating grizzly bears' salmon and terrestrial diets, but contributed little new information.

In this case study, a 55-year-old male farmer from Nepal with a kerion barbae in the beard region showed complete resolution after initiating oral itraconazole, highlighting the potential for misdiagnosis when bacterial superinfection complicates dermatophyte infections.

This review discusses the causes of alopecia, including androgenetic alopecia, and potential active ingredients for hair regrowth, but it does not report new clinical results.

This study found that pigmented vellus and upright regrowing hairs are the only predictive trichoscopic markers of hair regrowth in patients with alopecia totalis and universalis.

In this case study at Dr Batra’s® Homeopathy Clinic, a 15-year-old male with alopecia totalis experienced progressive hair regrowth and emotional well-being improvement over 4-5 months following a classical homeopathic treatment approach, despite previous conventional management.

In this study, researchers evaluated the effect of autologous platelet-rich plasma on hair regrowth in men with androgenetic alopecia, with results and specific findings not detailed in the abstract.

This study found that topical Hair UpTM appeared effective and safe for treating alopecia totalis and alopecia universalis, with high rates of terminal hair regrowth and notable cosmetic acceptability, particularly among minors.

This article discusses the potential of platelet rich plasma injections for treating hair loss but reports no new clinical results, emphasizing the need for further research.

This article reviews common causes of hair loss, noting that a well-directed history and examination are often sufficient for diagnosis, and reports no new clinical findings.

This article reviews recent advancements in hair transplantation techniques, particularly follicular unit transplantation, and suggests an expansion of its applications beyond male pattern hair loss, but reports no new results.

This article reviews the characteristics and distribution of alopecia areata and reports no new clinical results.

In this study, researchers found that applying mometasone furoate 0.1% cream combined with adapalene 0.1% gel resulted in significantly greater hair regrowth over 12 weeks compared to mometasone furoate cream alone in patients with alopecia areata.

This case series provides anecdotal evidence that urinary bladder extracellular matrix may improve hair regrowth in donor scars and enhance hair follicle graft outcomes in hair restoration surgery.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

In this case report, researchers observed hair regrowth in a patient with alopecia universalis and psoriasis after treatment with deucravacitinib, a TYK2 inhibitor, though they note spontaneous regrowth cannot be ruled out and suggest further controlled studies to evaluate its effects on alopecia areata.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

This systematic review suggests that topical ketoconazole may improve hair regrowth and thickness in both animal and human studies for androgenetic alopecia, but further randomized controlled trials are needed.

This review article provides an updated overview of the pharmacology, mechanism of action, clinical efficacy, and adverse events associated with topical minoxidil, a widely used treatment for androgenetic alopecia and other hair loss conditions, while noting that its exact mechanism is still not fully understood.

This retrospective review found that while intralesional corticosteroids provided symptomatic improvement for lichen planopilaris, hydroxychloroquine with topical corticosteroids led to higher remission rates but did not result in visible hair regrowth.

This study found that topical clobetasol propionate cream provided a modest improvement in hair regrowth for alopecia areata patients, though those with atopy had higher relapse rates after treatment completion.

This study reported that atypical variants of alopecia areata made up less than 25% of all cases in their specialized trichology unit, suggesting a potential selection bias.

In this study, using a combination of topical minoxidil (2%) and isotretinoin (0.05%) gel led to complete hair regrowth in 83.3% of alopecia areata patients within six months, demonstrating effective and well-tolerated treatment results.

This study found that beard hair in hair restoration procedures showed the highest survival rate and lowest anagen effluvium compared to scalp and chest hair.

This article discusses the similarities between alopecia areata and Indralupta in Ayurveda and reports no new clinical results, highlighting traditional and modern management approaches for the condition.

This review discusses the promising role of JAK inhibitors in managing alopecia areata, reporting significant hair regrowth and acceptable safety profiles but noting the need for further research on dosing and long-term safety.

This study suggests that topical minoxidil could promote hair regrowth in individuals with alopecia areata by exerting a localized immunosuppressive effect, and that combining minoxidil with other treatments may enhance hair growth outcomes.

This study found that topical minoxidil significantly enhanced facial hair growth in transgender individuals assigned female at birth undergoing gender affirming hormone therapy, with improvements most notable after six months of use.